0001062993-19-002344.txt : 20190517 0001062993-19-002344.hdr.sgml : 20190517 20190517174750 ACCESSION NUMBER: 0001062993-19-002344 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190515 FILED AS OF DATE: 20190517 DATE AS OF CHANGE: 20190517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Mark N CENTRAL INDEX KEY: 0001405235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 19837039 MAIL ADDRESS: STREET 1: 43 OVERLOOK ROAD CITY: OSSINING STATE: NY ZIP: 10562 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2019-05-15 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001405235 Wegman Mark N C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Common Stock, $0.001 par value 2019-05-15 4 M 0 15000 20.95 A 80272 D Stock Option (right to buy) 20.95 2019-05-15 4 M 0 15000 0 D 2019-06-24 Common Stock 15000 0 D The option vested monthly with respect to 1/12 of the total number of shares from the date of grant (6/25/2009). /s/ Mark N. Wegman, by Carl A. Valenstein, attorney-in-fact 2019-05-17